Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)
Status: Recruiting
Location: See all (6) locations...
Study Type: Observational
SUMMARY
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Stage I-IV HER2-positive breast cancer
Locations
United States
Kansas
KUCC - Indian Creek
ACTIVE_NOT_RECRUITING
Overland Park
KUCC - Overland Park
ACTIVE_NOT_RECRUITING
Overland Park
KUCC - Briarcliff
ACTIVE_NOT_RECRUITING
Westwood
KUCC - Olathe
ACTIVE_NOT_RECRUITING
Westwood
The University of Kansas Cancer Center
RECRUITING
Westwood
Missouri
KUCC - Lee's Summit
ACTIVE_NOT_RECRUITING
Lee's Summit
Contact Information
Primary
Study Coordinator
PRO-HER2@kumc.edu
913-588-6079
Time Frame
Start Date: 2024-09-27
Estimated Completion Date: 2044-10
Participants
Target number of participants: 1000
Treatments
HER2-positive breast cancer
Patients with stage I-IV HER2-positive breast cancer
Related Therapeutic Areas
Sponsors
Leads: Priyanka Sharma